Clinical and genetic characteristics of patients with autoimmune thyroid disease with anti-islet autoimmunity

Metabolism: Clinical and Experimental

Volumn 60, Issue 6, 2011, Pages 761-766

  Moriguchi, Masanori ^a   Noso, Sinsuke ^a   Kawabata, Yumiko ^a   Yamauchi, Takaaki ^a   Harada, Takeshi ^a   Komaki, Katsumori ^a   Babaya, Naru ^a   Hiromine, Yoshihisa ^a   Ito, Hiroyuki ^a   Yamagata, Satomi ^a   Murata, Kaori ^a   Higashimoto, Takahiro ^a   Park, Choongyong ^a   Yamamoto, Akinobu ^b   Ohno, Yasuhiro ^a   Ikegami, Hiroshi ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Takaishi City Medical Examination and Treatment Center   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GLUTAMATE DECARBOXYLASE ANTIBODY; HEMOGLOBIN A1C; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; INSULIN; INSULINOMA ASSOCIATED ANTIGEN 2 ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ANTI ISLET AUTOIMMUNITY; ARTICLE; AUTOIMMUNITY; BODY MASS; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GENOTYPE; GRAVES DISEASE; HAPLOTYPE; HASHIMOTO DISEASE; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; AUTOANTIBODIES; AUTOIMMUNE DISEASES; BODY MASS INDEX; DIABETES MELLITUS, TYPE 1; FEMALE; GENOTYPE; GLUTAMATE DECARBOXYLASE; HEMOGLOBIN A, GLYCOSYLATED; HLA ANTIGENS; HLA-DR ANTIGENS; HUMANS; ISLETS OF LANGERHANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; REPRESSOR PROTEINS; THYROIDITIS, AUTOIMMUNE;

EID: 79956081926     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2010.07.025     Document Type: Article

References (29)

1. Vaidya B, Kendall-Taylor P, Pearce SH. The genetics of autoimmune thyroid disease. J Clin Endocrinol Metab 2002;87:5385-97.
2. Atkinson MA, Eisenbarth GS. Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet 2001;358:221-9. (Pubitemid 32718550)
3. Yanagawa T, Mangklabruks A, DeGroot LJ. Strong association between HLA-DQA1*0501 and Graves' disease in a male Caucasian population. J Clin Endocrinol Metab 1994;79:227-9. (Pubitemid 24221187)
4. Katsuren E, Awata T, Matsumoto C, Yamamoto K. HLA class II alleles in Japanese patients with Graves' disease: weak associations of HLA-DR and -DQ. Endocr J 1994;41:599-603.
5. Heward JM, Allahabadia A, Daykin J, et al. Linkage disequilibrium between the human leukocyte antigen class II region of the major histocompatibility complex and Graves' disease: replication using a population case control and family-based study. J Clin Endocrinol Metab 1998;83:3394-7. (Pubitemid 28500861)
6. Yanagawa T, Hidaka Y, Guimaraes V, Soliman M, DeGroot LJ. CTLA-4 gene polymorphism associated with Graves' disease in a Caucasian population. J Clin Endocrinol Metab 1995;80:41-5.
7. Ueda H, Howson JM, Esposito L, et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 2003;423:506-11. (Pubitemid 36648570)
8. Kawabata Y, Ikegami H, Kawaguchi Y, et al. Asian-specific HLA haplotypes reveal heterogeneity of the contribution of HLA-DR and -DQ haplotypes to susceptibility to type 1 diabetes. Diabetes 2002;51:545-51. (Pubitemid 34764816)
9. Ikegami H, Awata T, Kawasaki E, et al. The association of CTLA4 polymorphism with type 1 diabetes is concentrated in patients complicated with autoimmune thyroid disease: a multicenter collaborative study in Japan. J Clin Endocrinol Metab 2006;91:1087-92. (Pubitemid 43357785)
10. Mimura G, Kida K, Matsuura N, et al. Immunogenetics of early-onset insulin-dependent diabetes mellitus among the Japanese: HLA, Gm, BF, GLO, and organ-specific autoantibodies - the J.D.S. study. Diabetes Res Clin Pract 1990;8:253-62. (Pubitemid 20111450)
11. Kawasaki E, Takino H, Yano M, et al. Autoantibodies to glutamic acid decarboxylase in patients with IDDM and autoimmune thyroid disease. Diabetes 1994;43:80-6.
12. Kordonouri O, Klinghammer A, Lang EB, Gruters-Kieslich A, Grabert M, Holl RW. Thyroid autoimmunity in children and adolescents with type 1 diabetes: a multicenter survey. Diabetes Care 2002;25:1346-50. (Pubitemid 41071144)
13. Powell M, Prentice L, Asawa T, et al. Glutamic acid decarboxylase autoantibody assay using 125I-labelled recombinant GAD65 produced in yeast. Clin Chim Acta 1996;256:175-88. (Pubitemid 27055806)
14. Maruyama T, Tanaka S, Shimada A, et al. Insulin intervention in slowly progressive insulin-dependent (type 1) diabetes mellitus. J Clin Endocrinol Metab 2008;93:2115-21. (Pubitemid 351831524)
15. Schmidli RS, Colman PG, Bonifacio E, Bottazzo GF, Harrison LC. High level of concordance between assays for glutamic acid decarboxylase antibodies. The First International Glutamic Acid Decarboxylase Antibody Workshop. Diabetes 1994;43:1005-9.
16. Murao S, Kondo S, Ohashi J, et al. Anti-thyroid peroxidase antibody, IA-2 antibody, and fasting C-peptide levels predict beta cell failure in patients with latent autoimmune diabetes in adults (LADA) - a 5-year follow-up of the Ehime study. Diab Res Clin Prac 2008;80:114-21.
17. Masuda M, Powell M, Chen S, et al. Autoantibodies to IA-2 in insulin-dependent diabetes mellitus. Measurements with a new immunoprecipitation assay. Clin Chim Acta 2000;291:53-66.
18. Awata T, Katsuren E, Matsumoto C, et al. Absence of shared HLA class II (DR, DQ)-linked genetic basis between IDDM and autoimmune thyroid disease in Japanese. Diabetes Care 1995;18:582-3.
19. Voorter CE, Rozemuller EH, de Bruyn-Geraets D, van der Zwan AW, Tilanus MG, van den Berg-Loonen EM. Comparison of DRB sequence-based typing using different strategies. Tissue Antigens 1997;49:471-6.
20. Voorter CE, Kik MC, van den Berg-Loonen EM. High-resolution HLA typing for the DQB1 gene by sequence-based typing. Tissue Antigens 1998;51:80-7.
21. Imanishi T, Akaza T, Kimura A, Tokunaga K, Gojobori T. Allele and haplotype frequencies for HLA and complement loci in various ethnic groups. In: Tsuji K, Aizawa M, Sasazuki T, editors. HLA 1991: Proceedings of the Eleventh International Histocompatibility Workshop and Conference. Oxford, UK: Oxford University Press; 1992. p. 1065-220.
22. Saito S, Ota S, Yamada E, Inoko H, Ota M. Allele frequencies and haplotypic associations defined by allelic DNA typing at HLA class I and class II loci in the Japanese population. Tissue Antigens 2000;56:522-9. (Pubitemid 32039363)
23. Takeda H, Kawasaki E, Shimizu I, et al. Clinical, autoimmune, and genetic characteristics of adult-onset diabetic patients with GAD autoantibodies in Japan (Ehime study). Diabetes Care 2002;25:995-1001. (Pubitemid 41110484)
24. Kawasaki E, Abiru N, Yano M, et al. Autoantibodies to glutamic acid decarboxylase in patients with autoimmune thyroid disease: relation to competitive insulin autoantibodies. J Autoimmun 1995;8:633-43.
25. Maugendre D, Verite F, Guilhem I, Genetet B, Allannic H, Delamaire M. Anti-pancreatic autoimmunity and Graves' disease: study of a cohort of 600 Caucasian patients. Eur J Endocrinol 1997;137:503-10. (Pubitemid 27505310)
26. Hiromatsu Y, Mukai T, Kaku H, et al. IL18 gene polymorphism confers susceptibility to the development of anti-GAD65 antibody in Graves' disease. Diabetic Med 2005;23:211-5.
27. Kasuga A, Maruyama T, Nakamoto S, Ozawa Y, Suzuki Y, Saruta T. High-titer autoantibodies against glutamic acid decarboxylase plus autoantibodies against insulin and IA-2 predicts insulin requirement in adult diabetic patients. J Autoimmun 1999;12:131-5. (Pubitemid 29130590)
28. Suzuki R, Shimada A, Maruyama T, et al. T-cell function in anti- GAD65+ diabetes with residual beta-cell function. J Autoimmun 2003;20:83-90. (Pubitemid 36207630)
29. Park MH, Park YJ, Song EY, et al. Association of HLA-DR and -DQ genes with Graves disease in Koreans. Hum Immunol 2005;66:741-7.